Comparison of Neutralizing Sars Cov-2 Igg Antibody Levels in Hospitalized Patients at Dr. Mohammad Hoesin Palembang Hospital

نویسندگان

چکیده

ABSTRACT COVID-19 is an acute respiratory disease that spreads rapidly throughout the world caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Published research on levels of SARS-CoV-2 antibodies in hospitalized patients still limited. Research sero-epidemiology and its correlation with clinical severity needed as a database for pandemic governance, especially neutralizing antibodies. This study was designed to compare IgG SARS CoV-2 tenth day various at RSUP Dr. Mohammad Hoesin Palembang. observational-analytic cross-sectional design. The conducted isolation ward RSMH Palembang from December 2021 March 2022. level measured confirmed COVID-19. Differences values were tested Mann Whitney test. effect confounding variables this using bivariate multivariate tests form chi-square test multiple linear regression scale dependent variable. included 50 patients, consisting 22 mild-moderate 28 severely-critically ill. Bivariate analysis showed there no significant difference between two groups. From data ROC curve, cut-off point predicting 500 AU/mL. more than AU/mL causes increased risk 3.69 (95% CI 1.13-11.98) times suffer severe-critical Serum found be significantly higher symptoms hospital. Keywords: COVID-19,

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Seroprevalence of anti-SARS-CoV-2 IgG antibody in healthcare workers: A report from Rafsanjan, Iran

Background: Healthcare workers (HCWs) have a high risk of SARS-CoV-2 infection. Seroprevalence studies can provide related data on HCWs who have a history of infections. According to numerous seroepidemiological reports of COVID-19 in different groups and the lack of seroepidemiological reports of COVID-19 in HCWs in Rafsanjan, the aim of this study was to determine the SARS-CoV-2 seroprevalenc...

متن کامل

Gastrointestinal Manifestations in Patients Infected with SARS-CoV-2

Coronavirus disease 2019, caused by severe acute respiratory syndrome coronavirus 2, has recently become the number one problem affecting global health. Coronavirus disease 2019 is principally recognized by its respiratory manifestations; however, recent studies have shown an increasing number of patients with gastrointestinal complaints like diarrhea, nausea, vomiting, and abdominal discomfort...

متن کامل

Assessment of protection against SARS-CoV-2 infection by measuring antibody titer, yes or no!

Dear Editor The current epidemic of the novel Coronavirus disease 2019 (COVID-19) risen from Wuhan, China, turned into a worldwide concern because of its incubation period (2-14 days) and its high transmission rate. The first cases of the infection were reported in December 2019 in Wuhan with symptoms like pneumonia for an unknown reason. Very soon it was known as a novel kind of Coronavirus o...

متن کامل

Designing an ELISA Method for Measurement of Human IgG and IgM Antibodies against SARS-CoV-2

Background and purpose: Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this study, an indirect ELISA method was designed to measure the human IgM and IgG antibodies against SARS-CoV-2. Materials and methods: Protein sequence of nucleocapsid antigen from SARS-CoV-2 was expressed in E. coli BL21 and then was...

متن کامل

A human SARS-CoV neutralizing antibody against epitope on S2 protein.

An immune antibody phage-display library was constructed from B cells of SARS convalescent patients. More than 80 clones were selected from the library by using the whole inactivated SARS-CoV virions as target. One human scFv, B1, was characterized extensively. The B1 recognized SARS pseudovirus in vivo and competed with SARS sera for binding to SARS-CoV with high affinity (equilibrium dissocia...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Manuju

سال: 2023

ISSN: ['2655-4712', '2655-2728']

DOI: https://doi.org/10.33024/mnj.v5i5.8515